Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

BRAIN UNDER PRESSURE WHY CEREBROSPINAL FLUID DESERVES STRATEGIC FOCUS IN HEALTHCARE

Healthcare Radius

|

July 2025

Knowing the significance, signs, developing solutions and integrating CSF awareness into standard care protocols can lead to a better patient experience and outcome, optimized resource allocation and leadership in a growing field of neurology.

- Dr. Roopesh Kumar, Director, Department of Neurosurgery at MGM Healthcare, Chennai

BRAIN UNDER PRESSURE WHY CEREBROSPINAL FLUID DESERVES STRATEGIC FOCUS IN HEALTHCARE

Cerebrospinal Fluid (CSF) related disorders remain the most unrecognized and misdiagnosed neurological conditions in clinical practice today. The recent public awareness, most importantly through the diagnosis of the legendary musician Billy Joel or also known as the piano man. These disorders can go undetected or mistaken for neurodegenerative diseases such as Parkinsons or Alzheimer’s.

The misdiagnosis of these disorders presents a clinical challenge. It leads to dragged out patient suffering, avoidable healthcare costs and inappropriate treatments. CSF represents an untapped market segment in brain health innovation, of stakeholders across the healthcare value chain such as clinicians, hospital administrators, device manufacturers, insurers, diagnostic companies and investors. And hence, it is time to pay attention to Cerebrospinal Fluid. With greater awareness, healthcare can invest in screening tools and updated protocols for treatment. The industry has an opportunity to change CSF related disorders from being under the radar to being commonly acknowledged and treated.

Estimated annual costs of delayed CSF diagnosis can be significant. However very limited data to put a figure to it precisely. It can be around 15,000 USD per person on an average.

imageThe CSF management market is estimated to be 2.5 Billion USD in 2024 and to grow to 3.8 Billion USD by 2021 (growth at CAGR-6.2%).

The CSF diagnostic market is 3300 Million USD in 2024, growing steadily at 5.3% year on year. The CSF Devices market in the US is estimated at 1.5 Billion USD in 2023.

Major players are (USA):

1. Medtronic

2. Integra

3. Natus medical

4. Sophysa

5. B Braun

Understanding CSF - More Than Brain Cushioning

FLERE HISTORIER FRA Healthcare Radius

Healthcare Radius

Healthcare Radius

ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL

Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?

If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.

time to read

3 mins

September 2025

Healthcare Radius

Healthcare Radius

HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY

HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT

Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA

Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI

Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM

SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL

Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS

Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.

time to read

9 mins

September 2025

Listen

Translate

Share

-
+

Change font size